World Journal of Urology

, Volume 28, Issue 2, pp 163–168 | Cite as

Thulium:YAG 2 μm cw laser prostatectomy: where do we stand?

  • T. Bach
  • S. J. Xia
  • Y. Yang
  • S. Mattioli
  • G. M. Watson
  • A. J. Gross
  • T. R. W. Herrmann
Topic Paper



Tm:YAG 2 μm cw laser prostatectomy was introduced in the treatment of benign ptostatic obstruction (BPO). Since then numerous studies have been published proving efficacy during follow-up. However, different surgical techniques were introduced with different names for similar techniques that complicate comparison. This reviews aim was to compare published data and break down surgical techniques to core points. The authors define validate appellations for different surgical techniques and propose further use of these names to ensure homogenous nomenclature.

Materials and methods

All publications on Thulium:YAG prostatectomy have been included in this review. Articles were reviewed and associated due to the nature of the surgical approach. A systematic review of published data was performed.


Sixteen peer-reviewed publications dealing with Tm:YAG laser prostatectomy were printed since 2005. Four different surgical principles are described, including vaporization, resection and enucleation. Follow-up, up to 24 months, showed durable functional results.


Efficacy of Tm:YAG prostatectomy was shown. Surgical techniques include “Tm:YAG Vaporization of the prostate (ThuVAP)”, “Tm:YAG VapoResection of the prostate (ThuVaRP)” and “Tm:YAG VapoEnucleation of the prostate (ThuVEP)”. The almost blunt enucleation is introduced as “Tm:YAG laser enucleation of the prostate (ThuLEP)”. The authors recommend the use of this neologism in the future. Further, large-scale prospective studies are needed to prove long-term durability. To initiate and canalize these upcoming studies, the Urothulium Study Group© was founded, combining international experts on Thulium:YAG laser prostatectomy under its roof.


Tm:YAG prostate Thulium (laser) prostate Thulium laser BPH Thulium laser prostatectomy Revolix 2 μm continuous wave laser 


Conflict of interest statement

There is no conflict of interest.


  1. 1.
    Xia SJ, Zhang YN, Lu J, Sun XW, Zhang J, Zhu YV, Li WG (2005) Thulium laser resection of prostate-tangerine technique in the treatment of benign prostatic hyperplasia. Zhonghua Yi Xue Za Zhi 85:3225–3228PubMedGoogle Scholar
  2. 2.
    Bach T, Herrmann TRW, Ganzer R, Burchardt M, Gross AJ (2007) RevoLix vaporesection of the prostate: initial results of 54 patients with a one-year follow-up. World J Urol 25:257–262CrossRefPubMedGoogle Scholar
  3. 3.
    Xia SJ (2009) Two-micron (thulium) laser resection of the prostate-tangerine technique: a new method for BPH treatment. AJA 11:277–281PubMedGoogle Scholar
  4. 4.
    Herrmann TR, Bach T, Imkamp F, Georgiou A, Burchardt M, Oelke M, Gross AJ (2010) Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol 28:45–51Google Scholar
  5. 5.
    Wendt-Nordahl G, Huckele S, Honeck P, Alken P, Knoll T, Michel MS, Haecker A (2008) Systemic evaluation of recently introduced 2-μm continuous-wave thulium laser for vaporesection of the prostate. J Endourol 22:1041–1045CrossRefPubMedGoogle Scholar
  6. 6.
    Bach T, Huck N, Wezel F, Haecker A, Gross AJ, Michel MS (2009) 70 vs. 120 W thulium:yttrium-aluminium-garnet 2 μm continuous-wave laser for the treatment of benign prostatic hyperplasia: a systemic ex-vivo evaluation. BJU Int (Nov 13 [Epub ahead of print])Google Scholar
  7. 7.
    Fu WJ, Hong BF, Yang Y, Zhang X, Gao JP, Zhang L, Wang XX (2008) Vaporesection for managing benign prostatic hyperplasia using a 2-μm continuous—wave laser: a prospective trial with 1-year follow-up. BJU Int 103:352–356CrossRefPubMedGoogle Scholar
  8. 8.
    Xia SJ, Zhuo J, Sun XW, Han BM, Shao Y, Zhang YN (2008) Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53:382–389CrossRefPubMedGoogle Scholar
  9. 9.
    Mattioli S, Munoz R, Recasens R, Berbegal C, Cortada J, Urmeneta JM, Teichmann H (2008) Treatment of benign prostatic hypertrophy with the Revolix laser. Arch Esp Urol 61:1037–1043PubMedGoogle Scholar
  10. 10.
    Szlauer R, Götschl R, Razmaria A, Paras L, Schmeller NT (2009) Endoscopic vaporesection of the prostate using the continuous-wave 2-μm thulium laser: outcome and demonstration of the surgical technique. Eur Urol 55:368–375CrossRefPubMedGoogle Scholar
  11. 11.
    Shao Q, Zhang FB, Shang DH, Tian Y (2009) Comparison of holmium and thulium laser in transurethral enucleation of the prostate. Zhonghua Nan Ke Xue 15:346–349PubMedGoogle Scholar
  12. 12.
    Bach T, Herrmann TRW, Ganzer R, Blana A, Burchardt M, Gross AJ (2009) Thulum:YAG vaporesection of the prostate. First results. Urologe 48:529–534CrossRefPubMedGoogle Scholar
  13. 13.
    Bach T, Wendt-Nordahl G, Michel MS, Herrmann TRW, Gross AJ (2009) Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate. World J Urol 27:541–545CrossRefPubMedGoogle Scholar
  14. 14.
    Bach T, Herrmann TRW, Haecker A, Michel MS, Gross AJ (2009) Thulium:yttrium-aluminium-garnet laser prostatectomy in men with refractory urinary retention. BJU Int 104:361–364CrossRefPubMedGoogle Scholar
  15. 15.
    Fu WJ, Zhang X, Yang Y, Hong BF, Gao JP, Cai W, Zhang P, Wang XX (2009) Comparison of 2-μm continuous wave laser vaporesection of the prostate and transurethral resection of the prostate: a prospective nonrandomized trial with 1-year follow-up. Urology 75:194–199Google Scholar
  16. 16.
    Bach T, Netsch C, Haecker A, Michel MS, Herrmann TRW, Gross AJ (2010) Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol 28:39–43Google Scholar
  17. 17.
    Heinrich E, Wendt-Nordahl G, Honeck P, Alken P, Knoll T, Michel MS, Haecker A (2010) 120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo model. J Endourol 24:75–79CrossRefPubMedGoogle Scholar
  18. 18.
    Naspro R, Bachmann A, Gilling P, Kuntz R, Madersbacher S, Montorsi F, Reich O, Stief C, Vavassori I (2009) A review of the recent evidence (2006–2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate. Eur Urol 55(6):1345–1357CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • T. Bach
    • 1
  • S. J. Xia
    • 2
  • Y. Yang
    • 3
  • S. Mattioli
    • 4
  • G. M. Watson
    • 5
  • A. J. Gross
    • 1
  • T. R. W. Herrmann
    • 6
  1. 1.Department of UrologyAsklepios Hospital BarmbekHamburgGermany
  2. 2.Shanghai Jiaotong University, Institute of UrologyShanghaiPeople’s Republic of China
  3. 3.Department of Urology301 PLA General HospitalBeijingPeople’s Republic of China
  4. 4.Urological Laser CenterMilanItaly
  5. 5.Eastbourne District General HospitalEastbourneUK
  6. 6.Department of UrologyMHH Medical School of HannoverHannoverGermany

Personalised recommendations